TY - JOUR
T1 - Computer-aided diagnosis of eyelid skin tumors using machine learning
AU - Zloto, Ofira
AU - Fogel, Ofir
AU - Ben Simon, Guy
AU - Rosner, Mordechai
AU - Vishnevskia-Dai, Vicktoria
AU - Hostovsky, Avner
AU - Klang, Eyal
N1 - Publisher Copyright:
© 2024 Canadian Ophthalmological Society
PY - 2024
Y1 - 2024
N2 - Objective: To develop an automated, new framework based on machine learning to diagnose malignant eyelid skin tumors. Methods: This study used eyelid lesion images from Sheba Medical Center, a large tertiary center in Israel. Before model training, we pretrained our models on the International Skin Imaging Collaboration (ISIC) 2019 dataset consisting of 25,332 images. The proprietary eyelid data set was then used for fine-tuning. The data set contained multiple images per patient, aiming to classify malignant lesions in comparison to benign counterparts. Results: The analyzed data set consisted of images representing both benign and malignant eyelid lesions. For the benign category, a total of 373 images were sourced. By comparison, for the malignant category, 186 images were sourced. For the final model, at sensitivity of 93.8% (95% CI 80.0–100.0%), the model has a corresponding specificity of 73.7% (95% CI 60.0–87.1%). To further understand the decision-making process of our model, we employed heatmap visualization techniques, specifically gradient-weighted Class Activation Mapping. Discussion: This study introduces a dependable model-aided diagnostic technology for assessing eyelid skin lesions. The model demonstrated accuracy comparable to human evaluation, effectively determining whether a lesion raises a high suspicion of malignancy or is benign. Such a model has the potential to alleviate the burden on the health care system, particularly benefiting rural areas, and enhancing the efficiency of clinicians and overall health care.
AB - Objective: To develop an automated, new framework based on machine learning to diagnose malignant eyelid skin tumors. Methods: This study used eyelid lesion images from Sheba Medical Center, a large tertiary center in Israel. Before model training, we pretrained our models on the International Skin Imaging Collaboration (ISIC) 2019 dataset consisting of 25,332 images. The proprietary eyelid data set was then used for fine-tuning. The data set contained multiple images per patient, aiming to classify malignant lesions in comparison to benign counterparts. Results: The analyzed data set consisted of images representing both benign and malignant eyelid lesions. For the benign category, a total of 373 images were sourced. By comparison, for the malignant category, 186 images were sourced. For the final model, at sensitivity of 93.8% (95% CI 80.0–100.0%), the model has a corresponding specificity of 73.7% (95% CI 60.0–87.1%). To further understand the decision-making process of our model, we employed heatmap visualization techniques, specifically gradient-weighted Class Activation Mapping. Discussion: This study introduces a dependable model-aided diagnostic technology for assessing eyelid skin lesions. The model demonstrated accuracy comparable to human evaluation, effectively determining whether a lesion raises a high suspicion of malignancy or is benign. Such a model has the potential to alleviate the burden on the health care system, particularly benefiting rural areas, and enhancing the efficiency of clinicians and overall health care.
UR - http://www.scopus.com/inward/record.url?scp=85203844253&partnerID=8YFLogxK
U2 - 10.1016/j.jcjo.2024.07.015
DO - 10.1016/j.jcjo.2024.07.015
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39214151
AN - SCOPUS:85203844253
SN - 0008-4182
JO - Canadian Journal of Ophthalmology
JF - Canadian Journal of Ophthalmology
ER -